
The link between cervical cancer and some types of human papillomavirus (HPV) has generated, in recent years, a great interest for the development of anti-HPV vaccines. The purpose of this article is to review the current perspectives for anti-HPV prophylactic vaccination and to describe the potential implications for the cervical cytology screening programs.
Human papillomavirus 16, Human papillomavirus 18, Papillomavirus Infections, Vaccination, Humans, Mass Screening, Uterine Cervical Neoplasms, Female, Papillomavirus Vaccines, Quality-Adjusted Life Years
Human papillomavirus 16, Human papillomavirus 18, Papillomavirus Infections, Vaccination, Humans, Mass Screening, Uterine Cervical Neoplasms, Female, Papillomavirus Vaccines, Quality-Adjusted Life Years
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
